S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: Asian shares shrug off Wall St blues as China leaves lending rate unchanged
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: Asian shares shrug off Wall St blues as China leaves lending rate unchanged
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: Asian shares shrug off Wall St blues as China leaves lending rate unchanged
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: Asian shares shrug off Wall St blues as China leaves lending rate unchanged
LON:ONC

Oncimmune (ONC) Share Price, News & Analysis

GBX 27.40
-0.60 (-2.14%)
(As of 04:33 AM ET)
Today's Range
26.40
28
50-Day Range
16.80
30.42
52-Week Range
13
45
Volume
15,916 shs
Average Volume
76,108 shs
Market Capitalization
£20.31 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ONC stock logo

About Oncimmune Stock (LON:ONC)

Oncimmune Holdings plc, an immunodiagnostics company, develops solutions for immuno-oncology, autoimmune disease and infectious diseases in the United Kingdom, North America, Europe, and internationally. It offers EarlyCDT-Lung, an immunodiagnostic blood test for detecting and identifying lung cancer; ImmunoINSIGHTS that enables life science organizations to optimize drug development and delivery; SeroTag discovery arrays for discovering and validating biomarkers for stratifying patients in multiple cancer indications, infectious diseases, and with various autoimmune diseases; and NavigAID, a disease-specific characterization panel. Oncimmune Holdings plc was incorporated in 2015 and is based in Leeds, the United Kingdom.

ONC Stock Price History

ONC Stock News Headlines

Oncimmune Holdings PLC
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)
AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.
The Unique Use of Liquid Biopsy
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)
AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.
Oncimmune Shares Fall on 1H Pretax Loss
FREENOME ACQUIRES GLOBAL IMMUNODIAGNOSTICS DEVELOPER ONCIMMUNE LTD
Cancer Biopsy Market Outlook by 2031
Oncimmune delivering top-line growth
See More Headlines
Receive ONC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Oncimmune and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/13/2018
Today
4/22/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
52
Year Founded
N/A

Profitability

Net Income
£-6,150,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£1.15 million
Cash Flow
GBX 2.29 per share
Book Value
GBX 1 per share

Miscellaneous

Free Float
N/A
Market Cap
£20.31 million
Optionable
Not Optionable
Beta
1.12
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Martin John Gouldstone (Age 58)
    CEO & Director
  • Mr. Martin Hudson
    Finance Director
  • Mr. Ron Kirschner (Age 45)
    COO, General Counsel & Company Secretary
  • Prof. Tariq Sethi B.Sc.
    FRCP, M.A., M.D., Ph.D., Chief Scientific Officer
  • Ms. Cléa Rosenfeld
    Head of Investor Relations
  • Mr. Maarten Brusse
    Chief Commercial Officer of Asia

ONC Stock Analysis - Frequently Asked Questions

How have ONC shares performed in 2024?

Oncimmune's stock was trading at GBX 25.20 on January 1st, 2024. Since then, ONC stock has increased by 8.7% and is now trading at GBX 27.40.
View the best growth stocks for 2024 here
.

How were Oncimmune's earnings last quarter?

Oncimmune Holdings plc (LON:ONC) issued its earnings results on Tuesday, February, 13th. The company reported ($5.70) EPS for the quarter. The company earned $0.08 million during the quarter. Oncimmune had a negative trailing twelve-month return on equity of 760.96% and a net margin of 356.25%.

What other stocks do shareholders of Oncimmune own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Oncimmune investors own include Actinium Pharmaceuticals (ATNM), Digi International (DGII), SeaChange International (SEAC), SMTC (SMTX), Axsome Therapeutics (AXSM), Chimerix (CMRX) and Constellation Pharmaceuticals (CNST).

How do I buy shares of Oncimmune?

Shares of ONC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:ONC) was last updated on 4/22/2024 by MarketBeat.com Staff

From Our Partners